Revealed! The most sold FTSE 100 stocks by Hargreaves Lansdown investors

Demand for these FTSE 100 stocks sank among Hargreaves Lansdown clients this year. But could they rebound in 2023?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Middle-aged white man pulling an aggrieved face while looking at a screen

Image source: Getty Images

The FTSE 100 index of stocks has performed more resolutely than many other major share bourses in 2022. But investor appetite hasn’t been robust across the Footsie.

In fact, the following FTSE index shares were the most sold of all UK and UK stocks — as well as investment trusts and exchange-traded funds — by Hargreaves Lansdown investors this year.

Here are the British stocks which experienced the highest number of net sells in 2022.

The wrong medicine

Unfashionable AstraZeneca’s (LSE: AZN) share price has endured a “volatile” time in 2022, Hargreaves Lansdown comments.

It says that “research and development is the engine of Astra’s long-term growth, and although it’s enjoyed a string of major approvals this year, this is a risky endeavour and there are no guarantees of Astra’s success”.

Drugs development is a highly unpredictable business. Problems at the R&D stage can result in enormous profits-sapping extra costs. Earnings forecasts can be left in tatters too if a drug in a fast-growing treatment area fails to get past regulators.

But AstraZeneca has a great track record of success in the laboratory. That’s why it had a colossal market-cap north of £175bn. In December alone, it received a string of approvals from the EU for various cancer and cardiovascular drugs.

Banking stock falls

HSBC has also been heavily sold by Hargreaves Lansdown customers in 2022. The share price here has been extremely choppy throughout 2022 as investors have reacted to the ongoing Covid-19 crisis in China.

The bank sources the lion’s share of profits from Asia. So worries over the Chinese economy — and the knock-on effect of slowing growth on the rest of the region — have climbed this year. Concerns over the country’s real estate sector have also sapped investor confidence.

The easing of lockdown restrictions in China might help HSBC’s profits recover looking ahead however. The Asian banking market is tipped for strong long-term growth as wealth levels there balloon.

Tech troubles

Meanwhile, Hargreaves Lansdown notes that “the trials of big tech this year is also showing up in investor behaviour with the tech heavy Scottish Mortgage Investment Trust”.

This FTSE 100 share has suffered as worries over tech-focused growth stocks have grown. Its core holdings include semiconductor manufacturing equipment supplier ASML, electric vehicle (EV) manufacturer Tesla and online retail giant Amazon.

Scottish Investment’s share price slipped sunk 44% in 2022. However, a shallower-than-expected economic slowdown next year could help it recover ground.

Oil stocks slip

Oil majors BP and Shell were also among the most highly sold on Hargreaves Lansdown’s investment platform this year.

The firm said that “sky-high oil and gas prices kept the cash pouring in” in 2022. But it added that cautious investors have been booking profits following recent share price gains, noting that “profits will pump less vigorously in 2023”.

The ongoing war in Ukraine could support oil prices next year. So could continued production cuts by influential OPEC+ countries.

However, profits at Shell and BP might fall off a cliff as the global economy slows and oil demand weakens. The rise of renewable energy poses a significant risk in 2023 and beyond too.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended ASML, Amazon.com, HSBC Holdings, Hargreaves Lansdown Plc, and Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Happy parents playing with little kids riding in box
Investing Articles

Up 12% in a month, Hollywood Bowl is a UK dividend stock on a roll

This 5%-yielding dividend stock was one of the top performers in the FTSE 250 index today. What sent it flying…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

Young investors are taking the stock market on a rollercoaster ride. Here’s how retirees can buckle up

Mark Hartley reveals the volatile impact that younger investors are having on the stock market and how UK retirees can…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

£7,500 invested in Aviva shares 5 years ago is now worth…

A lump sum pumped into Aviva shares half a decade ago has grown a lot. Andrew Mackie looks at the…

Read more »

Young female hand showing five fingers.
Investing Articles

Could £20,000 invested in these 5 dividend shares produce £14,760 of passive income over the next 10 years?

James Beard considers the potential of dividend shares to deliver amazing levels of passive income. Here are five that have…

Read more »

Workers at Whiting refinery, US
Investing Articles

At 570p, is it too late to consider buying BP shares?

Since the end of February, when the conflict in the Middle East started, BP shares have soared nearly 20%. But…

Read more »

Aviva logo on glass meeting room door
Investing Articles

5 years ago, £5,000 bought 1,231 Aviva shares. But how many would it buy now?

Buying Aviva shares in April 2021 would have been a good decision. And the insurance, wealth, and retirement group’s dividends…

Read more »

Nottingham Giltbrook Exterior
Investing Articles

5 years ago, £5,000 bought 3,185 Marks & Spencer shares. But how many would it buy now?

According to a recent survey, Marks & Spencer is the UK’s best brand. Does this mean it’s time to consider…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Is the 8.7% yield on this FTSE 250 stock too good to be true?

FTSE 250 stocks are often overlooked by income investors. Here’s one that’s currently (15 April) yielding over twice that of…

Read more »